The Healing Power of Botanical Therapeutics®

 
04-04-2012

In Respect of Holidays Herborium Group Planned Announcement Moved to the Following Week

Press Release: Herborium Group, Inc. – Wed, Apr 4, 2012 7:30 AM EDT

TEANECK, N.J., April 4, 2012 /PRNewswire/ -- Herborium Group, Inc. (HBRM.PK), www.herborium.com, has announced today that in respect of Good Friday and High Holidays of Passover and Easter it has moved its important announcement originally planned for Friday April 6th to Tuesday April 10th, 2012.

In addition, Dr. Agnes Olszewski, CEO of Herborium gave a short update on a very successful progress of the company's Social Media  and Promotional Strategy.

April brings an interview with Dr. Olszewski on one of the 5 most popular women's targeting websites www.hellogiggles.com launched by actress/singer/cotton spokesperson Zooey Deschanel.  On April 25-28 Dr. Olszewski will participate in a National Publicity Summit in New York City where she meets top US media.

About Herborium Group, Inc.

Herborium Group, Inc., a Botanical Therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals.  The Company uses clinical validation to establish and maintain a differential advantage. The company sales its products in the US and Europe. For more information, please visit www.herborium.com and www.acnease.com

One of our most important responsibilities is to communicate with shareholders in an open and direct manner.  Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends."  We cannot promise future returns.  Our statements reflect our best judgment at the time, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events.  The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission.

For more information please inquire: Investorsrelations@herborium.com

 

 

 

Information provided on Herborium.com about medical conditions, symptoms, and related products is not intended to be a substitute for professional medical advice. Visitors to this site should not use this information to diagnose or treat a health problem, symptom, concern or disease without consulting with their individual qualified healthcare provider. Statements contained on this website have not been evaluated by the FDA. Herborium products are not intended to diagnose, heal, cure or prevent disease.